Noxopharm Limited Stock Probability of Future Pink Sheet Price Finishing Under 0.0003
Noxopharm's future price is the expected price of Noxopharm instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Noxopharm Limited performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please specify Noxopharm's target price for which you would like Noxopharm odds to be computed.
Noxopharm |
Noxopharm Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Noxopharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Noxopharm Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Noxopharm Limited has some characteristics of a very speculative penny stock | |
| Noxopharm Limited has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.43 M. Net Loss for the year was (18.67 M) with loss before overhead, payroll, taxes, and interest of (2.35 M). | |
| Noxopharm Limited has accumulated about 14.01 M in cash with (13.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 34.0% of the company outstanding shares are owned by corporate insiders |
Noxopharm Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Noxopharm Pink Sheet often depends not only on the future outlook of the current and potential Noxopharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Noxopharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 292.2 M |
Noxopharm Technical Analysis
Noxopharm's future price can be derived by breaking down and analyzing its technical indicators over time. Noxopharm Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Noxopharm Limited. In general, you should focus on analyzing Noxopharm Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Noxopharm Predictive Forecast Models
Noxopharm's time-series forecasting models is one of many Noxopharm's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Noxopharm's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Noxopharm Limited
Checking the ongoing alerts about Noxopharm for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Noxopharm Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Noxopharm Limited is way too risky over 90 days horizon | |
| Noxopharm Limited has some characteristics of a very speculative penny stock | |
| Noxopharm Limited appears to be risky and price may revert if volatility continues | |
| Noxopharm Limited has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.43 M. Net Loss for the year was (18.67 M) with loss before overhead, payroll, taxes, and interest of (2.35 M). | |
| Noxopharm Limited has accumulated about 14.01 M in cash with (13.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 34.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Noxopharm Pink Sheet
Noxopharm financial ratios help investors to determine whether Noxopharm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Noxopharm with respect to the benefits of owning Noxopharm security.